New CFOs for Generation Bio, IQVia; plus changes at Gracell, AskBio, Replimune, Triplet, Twist, Cellectis, Verrica and more

Fresh off its $200 million IPO last month, Generation Bio Co. (NASDAQ:GBIO) has added Matthew Norkunas as CFO. Norkunas, who succeeds interim CFO Stephen DiPalma, was CFO of SomaLogic Inc.

IQVia Holdings Inc. (NYSE:IQV) has hired Ron Bruehlman as EVP and interim

Read the full 414 word article

How to gain access

Continue reading with a
two-week free trial.